Drug Cost Development of Citalopram and Fluoxetine Following the Introduction of Generic Substitution in Finland

Author： Aalto-Setälä Ville   Kanerva Risto   Bell J. Simon  

Publisher： Adis International

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.21, Iss.5, 2007-01, pp. : 363-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olanzapine: Akathisia following generic substitution: case report

By  

Reactions Weekly, Vol. 1, Iss. 1410, 2012-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite

Why people refuse generic substitution: a population survey of public opinion on generic substitution in Finland

By Heikkilä Reeta  

Drugs & Therapy Perspectives, Vol. 28, Iss. 8, 2012-08 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Consumer Perceptions of Generic Drug Substitution Practices in the USA

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 4, 2004-12 ,pp. : 262-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost Effectiveness of Venlafaxine Compared with Generic Fluoxetine or Generic Amitriptyline in Major Depressive Disorder in the UK

By Lenox-Smith Alan  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 173-184

Adis International

Access to resources Recommend Favorite

The Importance of Achieving Additional Drug Benefits at a Reasonable Cost: A Review of the Fluoxetine Years

By Freemantle N.   Mason J.  

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 319-324

Adis International

Access to resources Recommend Favorite